Quick Links

 Research Collaborations

City of Hope is a leader in translational research – a seamless pathway of basic science, clinical research and patient care that empowers important advances in medical progress.

Collaboration is an essential element of translational research, both internally through a multidisciplinary team approach to research and care, and externally through partnerships with other institutions.

City of Hope works with medical and academic centers around the country and internationally on research studies to advance our understanding about cancer, its causes, prevention and treatment. Additionally, our Office of Technology Licensing enables us to work with partnering companies to help develop and bring our scientific discoveries to market for the benefit of all patients.

 Press Releases
1/17/2012 - Smita Bhatia, physician and researcher at City of Hope, elected to American Society for Clinical Oncology board of directors

Smita Bhatia, M.D., M.P.H., the Ruth Ziegler Chair in Population Sciences at City of Hope, has been elected to serve on the board of directors of the American Society for Clinical Oncology (ASCO). Her four-year term will begin during ASCO’s annual meeting at Chicago in early June.
11/28/2011 - Childhood cancer survivors with specific genes are at higher risk of developing heart problems after treatment with anthracycline chemotherapy

The study, published in the Journal of Clinical Oncology, found that a specific variation of the CBR3 gene is linked to the development of cardiovascular complications. Investigators are conducting further research to develop tests and treatment guidelines that may reduce or mitigate this risk.
11/23/2011 - Brain imaging, behavior research reveals physicians learn more by paying attention to failure

When seeking a physician, you should look for one with experience. Right? Maybe not. Research on physicians' decision-making processes has revealed that those who pay attention to failures as well as successes become more adept at selecting the correct treatment.

11/15/2011 - City of Hope researchers discover genetic markers that put lymphoma survivors at higher risk for secondary leukemia

A team of City of Hope researchers has discovered genetic markers that help identify which patients might be at risk, and are closer to understanding how physicians may prevent certain patients from developing this deadly secondary cancer. The study was published in the Nov. 15 edition of the journal Cancer Cell.
11/10/2011 - Children’s Hospital Los Angeles and City of Hope Researchers Receive NCI Program Project Grant to Investigate Neuroblastoma Tumor Microenvironment

A $2.5 million grant from the National Cancer Institute (NCI)’s Tumor Microenvironment Network will enable cancer researchers from City of Hope and Children’s Hospital Los Angeles to investigate drug resistance in neuroblastoma.

 Search
Go!
Advanced Search Options
News & Publications Search
© 2012 City of Hope.
1500 East Duarte Road
Duarte, California 91010
626-256-HOPE (4673)
NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.